Pharmacology

Public health

Shorter treatment for malaria

New drug proves as effective at preventing recurrences as current medications with longer courses

By

Interview

2024 could become the year with the highest number of dengue cases

FAMERP virologist Maurício Nogueira discusses the characteristics of the current epidemic and the need for the health system to prepare for more patients

By

Pharmacology

Reinforcement against rabies

Experimental synthetic drug evaluated as alternative means of fighting the human rabies virus

By

Medicine

Spiders, allies of men

The Brazilian wandering spider serves as inspiration for erectile dysfunction drug

By

INTERVIEW

David MacMillan: A catalyst for discoveries

Chemist won the Nobel Prize in 2021 for important innovations in the pharmaceutical industry

By

PHARMACOLOGY

A potential vaccine against cocaine abuse

Vaccine stimulates the production of antibodies against cocaine in animal experiments

By

Medicine

Medicinal cannabis seeds on sale in Argentina

Medicinal cannabis seeds approved for sale in Argentina

By

Pharmacology

Psychedelics act against depression by stimulating connections between neurons

Antidepressant effect occurs independently of the mechanism that alters perception of reality

By

COVID-19

Setbacks in coronavirus drug development

Health agencies are suspending the use of drugs that have lost efficacy against circulating variants of SARS-CoV-2

By

Health

More powerful sunscreens

Antioxidant rosmarinic acid improves blocking of ultraviolet rays in sunscreen

By

COVID-19

Thai version of vaccine similar to ButanVac induces good immune response

In phase 1 trials involving 210 people, the low-cost formulation produced more neutralizing antibodies than the Pfizer / BioNTech vaccine

By

IMMUNOLOGY

Butantan’s dengue vaccine is 80% effective

The vaccine offered protection against two serotypes of the virus in the final phase of human trials

By

IMMUNOLOGY

Construction begins on Brazil’s new National Vaccine Center in Belo Horizonte

The institution will function as a link between basic immunobiological research and final products

By

Health

Immune cells increase pain from nerve damage

Immune cells increase chronic pain from nerve damage

By

RETROSPECT

The science rebel

Credited with discovering bradykinin, Maurício Oscar da Rocha e Silva fought to overcome the narrow-mindedness within scientific institutions before his death 40 years ago

By

IMMUNOLOGY

Three Brazilian COVID-19 vaccines begin human testing

The three candidates use different technologies; two have already completed the first phase of clinical trials

By

Chemistry

Collaboration to fight drug resistance

Seven pharmaceutical companies pledge to share surveillance data on antimicrobial resistance

By

PUBLIC SPENDING

SUS to save money as patent extensions come to an end

Expenditure on nine drugs could be reduced by R$3.9 billion, according to UFRJ estimates

By

COVID-19

Anti-coronavirus semiconductors

Nanotechnological materials emerge as promising alternatives in the battle against SARS-CoV-2 and future pandemics

By

photolab

Light sensors

In the lab, zebrafish larvae become covered in green glowing dots when exposed to certain drugs or pollutants

By

Health

Nasal COVID-19 vaccine

Research into intranasal vaccines against Covid-19 is advancing

By

COVID-19

Another step towards a universal vaccine

Clinical trials begin for broad-spectrum vaccines designed to offer protection against multiple coronaviruses

By

COVID-19

New coronavirus drugs

Pharmaceuticals announce orally administered drugs designed to treat the disease caused by SARS-Cov-2

By

Health

Focus on the bacillus

Fast, portable, and sensitive, a new test could be a useful tool for preventing leprosy and helping with early diagnosis.

By

COVID-19

The quest for a Brazilian vaccine

Researchers are testing a range of technologies, but few initiatives will receive the funding needed for costly phase 3 clinical trials

By

Covid-19

New COVID-19 drug

An antiviral pill developed by pharmaceutical company Pfizer reduced the risk of death and hospitalization in people recently diagnosed with Covid-19 by 89% compared to a placebo

By

COVID-19

Two vaccines safe for children

The CoronaVac vaccine, produced in Brazil by the Butantan Institute, is safe for children and adolescents, with no major side effects

By

Pharmacology

University of Oxford in Brazil

The Brazilian Ministry of Health signed a term of commitment with the University of Oxford, UK, to establish a clinical research and development center in Rio de Janeiro for the British institution’s drugs and vaccines

By

Nuclear medicine

Radiopharmaceuticals under threat

Radiopharmaceutical crisis leads to debate over production model

By

HEALTH

Pioneering immunization

Malaria vaccine recommended for children in Africa by the WHO is the first to protect humans from a parasite

By